Nix makes biosensors that analyze electrochemical biomarkers to deliver health and wellness data to consumers.
Nix has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
Nix's investors include Techstars, Shorewind Capital, Capital Q® Ventures Inc., Seed Round Capital, Great Oaks Venture Capital.
Nix is headquartered in Norwell, United States.
Nix makes biosensors that analyze electrochemical biomarkers to deliver health and wellness data to consumers.
Nix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nix — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/nix. Accessed October 30, 2026.
VCBacked. (2026). Nix — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/nix
{{cite web |title=Nix — Funding & Investors |url=https://www.vcbacked.co/company/nix |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated